NeuroSigma Announces FDA 510(k) Submission for Second Generation Monarch eTNS System
07 nov. 2023 08h50 HE
|
NeuroSigma, Inc.
LOS ANGELES, Nov. 07, 2023 (GLOBE NEWSWIRE) -- NeuroSigma today announced it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for its second-generation...
Catalyst Pharmaceuticals Reports FDA Approval of AGAMREE® (vamorolone) for Duchenne Muscular Dystrophy Granted to Santhera Pharmaceuticals
26 oct. 2023 15h19 HE
|
Catalyst Pharmaceuticals, Inc.
AGAMREE® Indicated for the Treatment of Duchenne Muscular Dystrophy for Patients Aged Two Years and Older Catalyst Holds the Exclusive North American License to Commercialize AGAMREE (vamorolone) for...
Accarent Health Offers Industry Leading Pediatric Network of Excellence
23 oct. 2023 12h48 HE
|
Accarent Health
Baltimore, MD, Oct. 23, 2023 (GLOBE NEWSWIRE) -- While most hospitals can treat children adequately for a broken bone or fever, relatively few children, compared with the total patient population,...
Mental Health Concerns for Children Approaching National Health Emergency in the U.S.
04 oct. 2023 14h38 HE
|
Omada Foundation for Children
LAGUNA BEACH, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Mental health is the top pediatric safety concern in the United States for 2023, according to a new report from U.S. patient safety and...
Dextromethorphan Market revenue to reach USD 550 Million by 2035, says Research Nester
20 sept. 2023 07h30 HE
|
Research Nester
New York, Sept. 20, 2023 (GLOBE NEWSWIRE) -- The global dextromethorphan market size is slated to expand at ~4% CAGR between 2023 and 2035. The market is poised to garner a revenue of USD 550...
Patient Return Electrodes Market revenue to surpass USD 343 Million by 2035, says Research Nester
24 août 2023 05h00 HE
|
Research Nester
New York, Aug. 24, 2023 (GLOBE NEWSWIRE) -- The global patient return electrodes market size is poised to grow at a CAGR of over ~7% from 2023 to 2035. The market is anticipated to garner a revenue...
Fecal Calprotectin Test Market revenue to hit USD 350 Million by 2035, says Research Nester
23 août 2023 07h30 HE
|
Research Nester
New York, Aug. 23, 2023 (GLOBE NEWSWIRE) -- The global fecal calprotectin test market size is predicted to grow at a CAGR of over ~12% from 2023 to 2035. The market is projected to garner a revenue...
Globus Medical Announces Launch of the MARVEL™ Growing Rod System, the company’s first product designed specifically for early onset scoliosis
31 juil. 2023 08h30 HE
|
Globus Medical
AUDUBON, Pa., July 31, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of the MARVEL™ Growing Rod...
Catalyst Pharmaceuticals Acquires Exclusive North American License For Vamorolone for Duchenne Muscular Dystrophy from Santhera Pharmaceuticals
19 juil. 2023 06h00 HE
|
Catalyst Pharmaceuticals, Inc.
Vamorolone is a Promising Best-In-Class Dissociative Anti-Inflammatory Steroid Treatment for Duchenne Muscular Dystrophy Synergistic Novel Asset Leverages Catalyst's Expertise and Bolsters...
Swinging for Hope – Bunzl Raises Record Funds for Revolutionary Pediatric Brain Tumour Treatment
13 juil. 2023 14h25 HE
|
Bunzl Canada Inc
BURLINGTON, Ontario, July 13, 2023 (GLOBE NEWSWIRE) -- Bunzl Canada is proud to have hosted its 23rd annual Ripple of Hope golf tournament in support of the Arthur & Sonia Labatt Brain Tumour...